These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
58 related items for PubMed ID: 1064681
1. The effect of pretreatment with allogeneic fetal cells on hamster melanoma. El-Domeiri AA, Sabet TY, Das Gupta TK. J Med; 1976; 7(2):103-12. PubMed ID: 1064681 [Abstract] [Full Text] [Related]
2. Retardation of growth of melanoma transplants in hamsters injected with fetal cells. el-Domeiri AA, Sabet TY, Das Gupta TK. Surg Forum; 1973; 24():123-4. PubMed ID: 4805964 [No Abstract] [Full Text] [Related]
3. Differential extraction of tumor-specific transplantation antigen and embryonic antigen from simian virus 40- and adenovirus 7-induced sarcoma cells of hamsters with 1-butanol and 3 M potassium chloride. Coggin JH, Gillis LD, Payne WJ. J Natl Cancer Inst; 1984 Apr; 72(4):853-62. PubMed ID: 6323810 [Abstract] [Full Text] [Related]
4. Fetal antigens as tumor growth enhancing factors in Yoshida's tumor rats. Mangano A, Turnaturi MC, Floridia V, Cosenza C, Condorelli F, Foti L. Boll Soc Ital Biol Sper; 1990 Nov; 66(11):1105-12. PubMed ID: 2095821 [Abstract] [Full Text] [Related]
5. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials. LeGrue SJ, Hearn DR. Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449 [Abstract] [Full Text] [Related]
6. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test. Kozłowska K, Zurawska-Czupa B, Kostulak A. Arch Immunol Ther Exp (Warsz); 1981 Nov; 29(1):137-42. PubMed ID: 7283676 [Abstract] [Full Text] [Related]
11. Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity. Palucka AK, Ueno H, Connolly J, Kerneis-Norvell F, Blanck JP, Johnston DA, Fay J, Banchereau J. J Immunother; 2006 Nov; 29(5):545-57. PubMed ID: 16971810 [Abstract] [Full Text] [Related]
12. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor. Hoon DS, Banez M, Okun E, Morton DL, Irie RF. Cancer Res; 1991 Apr 15; 51(8):2002-8. PubMed ID: 1901239 [Abstract] [Full Text] [Related]
13. Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma. Wang F, Bade E, Kuniyoshi C, Spears L, Jeffery G, Marty V, Groshen S, Weber J. Clin Cancer Res; 1999 Oct 15; 5(10):2756-65. PubMed ID: 10537339 [Abstract] [Full Text] [Related]
14. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16]. Gankovskaia LV, Pyl'nova TI, Sokolova EV, Koval'chuk LV. Biull Eksp Biol Med; 1980 Sep 15; 90(9):346-8. PubMed ID: 7000202 [Abstract] [Full Text] [Related]
16. ADCC against hamster transplantable melanoma cells in relation to the diversity of their cell surface. Kozłowska K, Kostulak A, Zurawska-Czupa B. Neoplasma; 1988 Sep 15; 35(5):503-10. PubMed ID: 3063982 [Abstract] [Full Text] [Related]
20. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response. Stackpole CW, Demsey A. Invasion Metastasis; 1984 Sep 15; 4(1):28-46. PubMed ID: 6329988 [Abstract] [Full Text] [Related] Page: [Next] [New Search]